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BACKGROUND: Not only hypertension, pre-hypertension has been reported to be linked with increased cardiovascular morbidity and mortality 
risks as well. Prehypertension has three-fold hypertension 
and two-fold cardiovascular risks. Pathomechanism that 
links hypertension with cardiovascular is related with 
endothelial dysfunction and insulin resistance. Endothelial 
dysfunction occurs when nitric oxide (NO) biological 
function was impaired, whereas shown by asymmetric 
dimethylarginine (ADMA). Subjects with prehypertension 
had higher insulin resistance events than normotension, 
whereas shown by homeostatic model assessment-estimated 
insulin resistance (HOMA-IR). This research was conducted 
to investigate the correlation of HOMA-IR with ADMA in 
prehyper- and normo-tension.
METHODS: A cross-sectional comparative research 
was designed. Subjects were recruited and divided into 
prehyper- and normo-tensive groups. ADMA was measured 
using ELISA method, while HOMA-IR was calculated by 
the ratio of fasting insulin and glucose. Spearman 1-tail and 
Mann Whitney statistical analyses were performed.
RESULTS: Comparing to normotensive group, elevated 
levels of HOMA-IR and ADMA in prehypertensive group 
were shown, but not significant. In prehypertensive group, 
we found significant correlation between HOMA-IR and 
ADMA. 
CONCLUSION: Insulin resistance and endothelial 
dysfunction was elevated in prehyper-compared to normo-
tension.
LATAR BELAKANG: Selain hipertensi, prehipertensi juga telah dilaporkan berkaitan dengan peningkatan resiko morbiditas dan 
mortalitas yang berkaitan dengan kardiovaskuler. 
Prehipertensi memiliki resiko tiga kali lipat mengalami 
hipertensi dan dua kali lipat mengalami kardiovaskular. 
Patomekanisme yang menghubungkan hipertensi dengan 
kardiovaskular berhubungan dengan disfungsi endotel 
dan resistensi insulin. Disfungsi endotel terjadi apabila 
fungsi biologis NO  terganggu, dan parameter yang 
menggambarkan kondisi tersebut adalah asymmetric 
dimethylarginine (ADMA). Subyek dengan prehipertensi 
lebih resistensi insulin dibandingkan normotensi, dan 
parameter yang menggambarkan kondisi tersebut adalah 
homeostatic model assessment-estimated insulin resistance 
(HOMA-IR). Penelitian ini dilakukan untuk mengetahui 
korelasi ADMA dengan HOMA-IR pada prehiper- dan 
normo-tensi.
METODE: Dilakukan penelitian komparasi dengan 
rancangan potong lintang. Subyek direkrut dan dibagi 
menjadi grup hiper- dan normo-tensif. ADMA diukur 
dengan menggunakan metode ELISA, dan HOMA-IR 
dihitung dengan menggunakan rasio insulin dan gula puasa. 
Kemudian analisa statistik Spearman 1-tail and Mann 
Whitney dilakukan.
HASIL: Hasil penelitian menunjukkan terdapat peningkatan 
kadar HOMA-IR dan ADMA pada kelompok prehipertensi 
dibandingkan normotensi, namun tidak bermakna. Pada 
kelompok prehipertensi terdapat hubungan yang bermakna 
antara HOMA-IR dengan ADMA.
Abstract Abstrak
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Hypertension is an important public health issue, not only 
because of high prevalence, but also the cause of morbidity 
and mortality. In the world, the prevalence reached 1 billion, 
and hypertension-related death reached 7.1 million per year 
(1), due to increasing cardiovascular risk. (2) Hypertension 
and cardiovascular disease pathomechanism is related with 
interrelated and interacted endothelial dysfunction and 
insulin resistance, generating the complex mechanisms. 
(3) Endothelial dysfunction occurs when nitric oxide (NO) 
biological function was impaired, whereas asymmetric 
dimethylarginine (ADMA) is one of the parameters to 
assess the incidence of endothelial dysfunction.(4) ADMA, 
an L-arginine analogue, is a natural product of metabolism. 
ADMA will inhibit synthesis of NO, leading to endothelial 
dysfunction.(5) Hypertension has been reported to have 
relation with increase in insulin resistance, in which 
vascular inflammation is the core of their relationships.
(6-8) Pathomechanism linking hypertension with insulin 
resistance is not fully understood. Insulin was suggested 
to stimulate sympathetic nervous system, increase kidney 
sodium retention, modulate cation and induce vascular 
smooth muscle hypertrophy.(9)
 Insulin has several functions, the most important one is 
the regulation of glucose, and others such as vasodilatation, 
anti-apoptosis, anti-inflammation and anti-oxidation 
as defense mechanism for cardiovascular.(10) Insulin 
resistance is a condition in which cells become resistant to 
the effects of insulin, resulting normal response to insulin is 
reduced. Therefore higher levels of insulin are needed for 
optimal insulin function.
 According to the Joint National Committee, 
prehypertension was designated whereas systolic blood 
pressure (SBP) 120-139 mm Hg or diastolic blood pressure 
(DBP) 80-89 mmHg.(1) Subject with prehypertension had 
incidence increase of cardiovascular disease. Moreover, 
compared with normo-, the prehyper-tensive group 
had three-fold risk of hypertension and two-fold risk of 
cardiovascular.(11)
 Role of endothelial dysfunction and insulin resistance 
in elevating blood pressure was proven experimentally 
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KESIMPULAN: Terjadi peningkatan resistensi insulin dan 
disfungsi endotel pada prehiper- dibandingkan normo-tensi.




A cross-sectional study was designed. Subjects were 
recruited and selected based on blood pressure measurement 
(SBP & DBP) according to the Joint National Committee 
(1). Briefly, subjects with liver or kidney diseases, acute 
infections, anti-inflammatory or anti-oxidant drugs intake 
for 3 months, pregnant, were all excluded. Subjects were 
measured/tested for waist circumference (WC), SBP and 
DBP, which later divided into 2 groups: prehyper- and 
normo-tensive groups. All subjects were further tested for 
fasting plasma glucose (FPG), triglyceride, high density 
lipoprotein (HDL), low density lipoprotein (LDL), insulin, 
and ADMA.
Blood Collection and Biochemical Analyses
Blood were collected intravenously from all subjects. Serum 
was generated, stored and tested for all parameters. FPG, 
triglyceride, HDL and LDL were tested based on method 
routinely applied in clinical laboratory. For insulin test, we 
used 1 ReadyPack (Cat. No.: 02230141, Siemens Healthcare 
Diagnostics Inc., Tarrytown, NY). Briefly, 1 ReadyPack, 
named as The ADVIA Centaur Insulin assay, is a two-site 
sandwich immunoassay using direct chemiluminescent 
technology, which uses constant amounts of two antibodies. 
and clinically, however the mechanisms and dynamics of 
endothelial dysfunction and insulin resistance have not 
been elucidated. It was reported that prehypertension was 
correlated with insulin resistance in Japanese, Indian and 
American, but not in African American.(9) 
 In our current interest, we conducted a study to 
investigate the correlation of homeostatic model assessment-
estimated insulin resistance (HOMA-IR) with ADMA in 
prehyper- and normo-tension. As insulin resistance marker, 
both HOMA-IR and euglycaemic clamp method were 
correlated with insulin resistance.(12) Meanwhile ADMA 
was used as endothelial dysfunction marker, since ADMA 
inhibit NO synthesis and endothelial function, leading to 
incidence of atherosclerosis. ADMA levels were increased 
in subjects with hypertension, hypercholesterolemia, 
chronic heart failure, diabetes mellitus and chronic kidney 
disease.(13)
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Results
Discussion
In our current results, HOMA-IR and ADMA of 
prehypertensive group were higher than the ones of 
normotensive group. This might be related to the fact that 
hypertension is interrelated and interacted with endothelial 
dysfunction and insulin resistance.(3) ADMA is an 
endogenous inhibitor of endothelial NO synthesis (eNOS), 
was used as endothelial dysfunction parameter for this 
study. ADMA is synthesized from arginine residues and 
metabolized by dimethylarginine-dimethylaminohydrolase 
(DDAH) to citrulline. Increased concentration of ADMA 
was reported to have an association with endothelial 
dysfunction.(14) Meanwhile, HOMA-IR values was used 
as insulin resistance parameter for this study. Insulin has 
vasodilatory function through Phosphatidylinositol 3 
Kinase (PI3K) pathway whereby insulin increases eNOS, 
which will then produce NO. In insulin resistance condition, 
the insulin does not function optimally, causing lower NO 
production. Meanwhile ADMA acts as an inhibitor of 
eNOS activity, which can also lower down production of 
The first antibody is a monoclonal mouse anti-insulin 
antibody labeled with acridinium ester. The second antibody 
is a monoclonal mouse anti-insulin antibody, which is 
covalently coupled to paramagnetic particles.  Later on, 
HOMA-IR was calculated using formula: fasting insulin 
x fasting glucose / 22.5. To analyze ADMA, We used 
Enzyme Immunoassay for the Quantitative Determination 
of Endogenous Asymmetric Dimethylarginine (ADMA) 
in Serum or Plasma (Cat. No.: 17-EA201/96, DLD 
Gesellschaft für Diagnostika und medizinische GmbH, 
Hamburg, German). The substrate reaction was monitored 
at 450 nm.
Statistical Analysis
Statistical analyses were performed using SPSS for 
Windows version 15.0 (USA, SPSS Inc.).  To measure the 
difference significance of each parameter between prehyper- 
and normo-tensive groups, we used Mann Whitney analysis. 
Meanwhile, to measure the correlation significance of 
HOMA-IR with ADMA in each group, we used Spearman 
1-tail analysis.
Normotension (n=19) Prehypertension (n=43)
Average ± SD Average ± SD
WC (cm) 86.4 ± 9.0 90.3 ± 9.7 0.132
Age  (years) 40.4 ± 7.4 43.9 ± 9.0 0.126
DBP (mmhg) 71.3 ± 6.5 80.6 ± 4.5 0.000*
SBP (mmhg) 107.8 ± 7.1 124.9 ± 5.8 0.000*
FPG (mg/dL) 86.8 ± 8.2 93.2 ± 8.8 0.015*
Triglyceride (mg/dL) 96.7 ± 39.6 136.4 ± 91.1 0.011*
HDL (mg/dL) 48.0 ± 7.1 47.8 ± 9.2 0.536
LDL (mg/dL) 132.7 ± 28.8 137.9 ± 25.2 0.321
Insulin (ulU/mL) 7.2 ± 4.5 8.4 ± 6.1 0.703
HOMA-IR 1.547 ± 1.022 1.930 ± 1.415 0.449
ADMA (μmol/mL) 0.656 ± 0.075 0.678 ± 0.151 0.454
Test p value
Table 1. Subject characteristics, HOMA-IR and ADMA analyses in 
prehyper- and normo-tensive and groups.
* Mann Whitney test; Significant p value <0.05; SD: Standard Deviation
We found that DBP, SBP, FPG, triglyceride of prehyper- and 
normo-tension and were significantly different. HOMA-IR 
and ADMA of prehypertension were higher the ones of 
normotension, but not significant.
Based on Spearman 1-tail correlation analysis, we found 
HOMA-IR was negatively correlated with ADMA (r=-0.171, 
p=0.271) in normotensive group. Meanwhile HOMA-IR 
was significantly correlated with ADMA (r=0.330, p=0.018) 
in prehypertensive group. 
NO. These two mechanisms in turn will cause 
increased vasoconstriction. 
 It was reported previously that endothelial 
dysfunction and insulin resistance were 
correlated in elevating blood pressure.(9) 
Many cross-sectional studies have examined 
the relationship between insulin resistance/
sensitivity and endothelial function.(15-29) In 
these studies, endothelial function was evaluated 
by high resolution brachial artery ultrasound, 
venous occlusion plethysmography, and laser 
doppler imaging techniques. Insulin sensitivity 
was assessed by euglycemic hyperinsulinemic 
clamps and HOMA-IR.(15-29) These studies 
suggest that insulin resistance may only partly 
explain the impaired endothelial function. It is 
also possible that other manifestations of insulin 
resistance such as hyperglycemia, dyslipidemia, 
inflammation, and obesity may be intermediary 
Sixty-two subjects consisting of 43 prehyper- and 19 normo- 
tensive subjects, were selected according to inclusion and 
exclusion criteria. The study was approved by the Ethics 
committee of the University of Hasanuddin (UH09060072). 
All subject characteristics including WC, age, DBP, SBP, 
FPG, triglyceride, HDL and LDL, were obtained (Table 1). 
HOMA-IR and ADMA results were also obtained (Table 1). 
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mediators that act in concert with insulin resistance to 
mediate endothelial dysfunction.(15) Therefore, although 
we found HOMA-IR and ADMA of prehypertensive group 
were higher than the ones of normotensive group, we 
suggest that further study should be pursued in order to 
correlate other factors that might playing role in endothelial 




In the prehypertension group had an increase in endothelial 
dysfunction which is a risk for cardiovascular disease events 
in which the mechanisms of endothelial dysfunction in the 
prehypertension group affected by insulin resistance.
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